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Cohort profile
AbstrACt
Purpose In the Simple Intensive Care Studies-I (SICS-I), 
we aim to unravel the value of clinical and haemodynamic 
variables obtained by physical examination and critical 
care ultrasound (CCUS) that currently guide daily practice 
in critically ill patients. We intend to (1) measure all 
available clinical and haemodynamic variables, (2) train 
novices in obtaining values for advanced variables 
based on CCUS in the intensive care unit (ICU) and (3) 
create an infrastructure for a registry with the flexibility 
of temporarily incorporating specific (haemodynamic) 
research questions and variables. The overall purpose is to 
investigate the diagnostic and prognostic value of clinical 
and haemodynamic variables.
Participants The SICS-I includes all patients acutely 
admitted to the ICU of a tertiary teaching hospital in the 
Netherlands with an ICU stay expected to last beyond 
24 hours. Inclusion started on 27 March 2015.
Findings to date On 31 December 2016, 791 eligible 
patients fulfilled our inclusion criteria of whom 704 
were included. So far 11 substudies with additional 
variables have been designed, of which six were 
feasible to implement in the basic study, and two are 
planned and awaiting initiation. All researchers received 
focused training for obtaining specific CCUS images. An 
independent Core laboratory judged that 632 patients had 
CCUS images of sufficient quality.
Future plans We intend to optimise the set of variables 
for assessment of the haemodynamic status of the 
critically ill patient used for guiding diagnostics, prognosis 
and interventions. Repeated evaluations of these sets of 
variables are needed for continuous improvement of the 
diagnostic and prognostic models. Future plans include: 
(1) more advanced imaging; (2) repeated clinical and 
haemodynamic measurements; (3) expansion of the 
registry to other departments or centres; and (4) exploring 
possibilities of integration of a randomised clinical trial 
superimposed on the registry.
study registration number NCT02912624; Pre-results.
IntroduCtIon
Circulatory shock occurs in about one-third 
of all critically ill patients.1 These patients 
have an increased risk of multiorgan failure, 
long-term morbidity and mortality.2 3 A 
recent consensus statement on circulatory 
shock recommends to use a combination of 
clinical, biochemical and/or haemodynamic 
variables, varying from simple to advanced, 
for establishing the diagnosis and instiga-
tion of treatment.4 The consensus advocates 
frequent measurement of heart rate, blood 
pressure, body temperature, skin perfusion, 
urine output and mental status.4 If neces-
sary, more advanced and sequential haemo-
dynamic assessments using critical care 
ultrasound (CCUS) as preferred modality 
are recommended.4–7 Previous studies have 
found different prognostic or diagnostic 
variables, many have presented single or 
dual variable associations and no research 
has evaluated their additional value on top 
of the accepted predictors. Different studies 
highlight different predictors of mortality: 
low blood pressures,8–11 increased lactate 
levels,8 9 11–14 prolonged capillary refill 
times,15–17 skin mottling,18–20 oliguria21 22 and 
decreased cardiac output23 24 are identified 
as prognostic variables. These contrasting 
strengths and limitations of this study
 ► The large prospective design is powered to 
evaluate the value of combinations of clinical and 
haemodynamic variables for guiding decisions in 
acutely admitted critically ill patients.
 ► The flexible simple design allows expansions in time 
and/or place and/or other research questions.
 ► The basic study is limited to a one-time evaluation 
of variables.
 ► Critical care ultrasound measurements are not 
obtainable in all critically ill patients due to 
positioning issues or insufficient image quality.
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results are also seen in studies that investigated the value 
of clinical and biochemical variables for diagnosing 
shock.17 18 23 25–34 The reason for inconsistency of results 
in these studies potentially originate from several meth-
odological flaws, including improper research design, 
lack of confirmation cohorts and power and sample 
size issues. Several studies selected specific subpopula-
tions (eg, patients with sepsis,8–11 13 17 18 33 acute cardiac 
failure16 23 or trauma15) and some had a retrospective 
design or used convenience samples from large data-
bases.9–12 15 20 21 Most studies analysed single variable asso-
ciations rather than evaluating their additional predictive 
value on top of the widely accepted variables using multi-
variate models.8 17 18 21 23 Also, most had relatively small 
sample sizes.8–10 12 15–18 23 24 33
Both clinical and haemodynamic variables used for 
diagnosing shock are currently recommended as ‘best 
practice’.4 Both the consensus and the Surviving Sepsis 
Campaign guideline recommend further haemodynamic 
assessment (such as cardiac function) to determine the 
type of shock if the clinical examination does not lead to 
a clear diagnosis (best practice statement).4 35 Less inva-
sive devices are recommended instead of more invasive 
devices only when they have been validated in the context 
of patients with shock.4 36
The additive diagnostic and prognostic value of combi-
nations of clinical, biochemical and haemodynamic vari-
ables remains to be established with a higher quality of 
evidence. These variables have never been evaluated 
collectively in a large, unselected, prospective cohort of 
critically ill patients. Therefore, we established the Simple 
Intensive Care Studies-I (SICS-I) with the aim to evaluate 
the diagnostic and prognostic value of a comprehensive 
selection of clinical and haemodynamic variables in the 
critically ill. This paper describes the study protocol with 
the diagnostic and prognostic aims of the basic study as 
well as the characteristics of the patients included in the 
cohort so far. All substudies will be presented here for 
illustrative purposes without elaborating on each specific 
rationale and design.
Cohort desCrIPtIon
Participants
This prospective cohort study is conducted in the Depart-
ment of Critical Care of the University Medical Center 
Groningen (UMCG), a tertiary teaching hospital in the 
Northern part of the Netherlands. Our intensive care unit 
(ICU) has 44 beds divided over four subunits to which all 
types of critically ill adult patients are admitted. In our 
department, CCUS is available if considered indicated to 
inform practice but is not performed in each patient each 
day. We initiated our study in one unit to deal with start-up 
issues and to assess feasibility, including (1) whether it 
was logistically possible to include a broad population of 
acutely admitted critically ill patients, (2) whether all clin-
ical and haemodynamic measurements could be recorded 
within a limited time so that it did not obstruct routine 
patient care and (3) whether novices could obtain CCUS 
images of sufficient quality after training. The entire 
study was purely observational in design; no interventions 
were applied. After inclusion of our first patient on 27 
March 2015, we gradually expanded inclusions to all the 
four subunits of the department within 1 year.
All acutely admitted adult critically ill patients expected 
to stay beyond 24 hours were included on their first day 
of ICU admission. The attending intensivist estimated 
the expected duration of ICU treatment. Inclusions and 
measurements were obtained by medical research interns 
and PhD students who were not in any way involved in 
patient care. All measurements, including CCUS find-
ings, were not revealed to the care providers. If any 
possible abnormality was observed by CCUS, an indepen-
dent qualified intensivist was contacted for judgement 
of informing the attending intensivist. All researchers 
underwent a focused CCUS training by experienced 
cardiologist-intensivists. Following hospital regulations, 
patients or their legal representatives were informed 
and were excluded if they refused to participate. Other 
reasons for exclusion were acute psychiatric disorders, 
mental retardation, serious language barriers, continuous 
resuscitation efforts or mechanical circulatory support. 
The local institutional review board (Medisch Ethische 
Toetsingscommissie (METc) of the UMCG; M15.168207) 
approved the main study and the additional measures 
added when initiating the substudies (METc M11.104639 
and M16.193856).
registry, substudies and research questions
The cohort study was designed to register a set of baseline 
clinical, biochemical and haemodynamic variables in each 
included patient. In the initial basic study, we collected 
baseline demographic data, clinical data by protocolised 
physical examination and CCUS data to measure cardiac 
output (see online supplementary file 1). The co-primary 
aims are to determine the association between variables 
measured by physical examination and cardiac output 
and to assess the prognostic value of both the clinical 
and haemodynamic variables for 90-day mortality. The 
flexible design in terms of research questions, planning 
and data collection allows incorporation of substudies 
with additional measurements to assess the feasibility in 
terms of the quality of the measurements (figure 1). The 
designed substudies with their specific research questions 
and (temporarily) added variables are listed in table 1. 
After completion of SICS-I, we will analyse the variables 
to establish an optimised basic set of variables as SICS-II 
(figure 1).
data collection
On inclusion, we collected a clinical and haemody-
namic profile of each patient by physical examination, 
recording data from the bedside monitor as well as 
using CCUS. All variables and the measurements were 
predefined in a protocol (see online supplementary file 
1). In the current study, CCUS comprised transthoracic 
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echocardiography (basic study, substudies 1, 3–9 and 11), 
pulmonary ultrasound (substudy 3 and 10) and ultraso-
nography of the large arteries (substudy 5). The CCUS 
images and measurements were validated by an inde-
pendent core laboratory (Groningen Image Core Lab, 
UMCG, Groningen, the Netherlands, www. gicl. com). 
These echo laboratory technicians were blinded for all 
other measurements. Other variables such as laboratory 
values and diagnoses as judged by an ICU physician at 
ICU admission and discharge were obtained from the 
patient’s electronic medical records. Comorbidities, rele-
vant medical history and Acute Physiology and Chronic 
Health Evaluation II and IV (APACHE II and IV) scores 
were registered as well. All-cause mortality at 90-day 
follow-up was based on the municipal personal records 
database.
data management
The protocol of this study and its substudies was published 
on the intranet of our hospital before the start of the 
study (project number: 201500144) and, after comple-
tion of the pilot phase, was also registered at  clinicaltrials. 
gov (NCT02912624). A customised electronic case report 
form (e-CRF) was developed prior to study onset in 
OpenClinica version 3.9 (OpenClinica, LLC and collabo-
rators, Waltham, Massachusetts, USA). Patient data were 
pseudoanonymised and entered in OpenClinica, and a 
decoding list of included patients was kept separate from 
the e-CRF by the research office of the Department of 
Critical Care. All measurements, informed consent forms 
and other patient details were uploaded in OpenClinica 
and stored on a secure hospital server. Independent study 
monitoring of the organisation and the conduct of the 
study was in adherence to the Good Clinical Practice 
guidelines.37
FIndIngs to dAte
Characteristics of study population
Between 21 March 2015 and 31 December 2016, all 
eligible patients were identified by daily screening of all 
new patients admitted to the ICU (figure 2). Currently, 
704 patients have been included from a total of 791 
eligible patients. The mean age was 61 (±15) years and 457 
patients (65%, 95% CI 61% to 68%) were male. Table 2 
displays demographic data along with all haemodynamic 
variables of the basic study. There were no missing data for 
the following variables: blood pressures, heart rate, urine 
output, central temperature, arterial haemoglobin and 
lactate levels. Mottling scores, capillary refill times and 
peripheral temperatures had missing values in 2%–8% of 
the patients.
Reasons for missing data included a dark or icteric skin 
colour (mottling and capillary refill times) and compres-
sion stockings (capillary refill time at the knee and periph-
eral temperature at the dorsum of the foot).
Figure 1 Timeline of basic study line and substudies. The substudies are explained in table 1. AKI, acute kidney injury; ARDS, 
acute respiratory distress syndrome; NIRS, near-infrared spectroscopy; PEEP, positive end-expiratory pressure; RV, right 
ventricular; SICS, Simple Intensive Care Studies. 
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Vasopressors and/or inotropes were used in 363 patients 
(52%, 95% CI 48% to 55%), of whom 351 patients (50%, 
95% CI 46% to 54%) were given noradrenalin, 10 (1%, 
95% CI 1% to 3%) vasopressin, 29 (4%, 95% CI 3% to 6%) 
milrinone and 20 (3%, 95% CI 2% to 4%) dobutamine. 
In 46 patients (7%, 95% CI 5% to 9%), more than one 
type of vasopressor or inotrope was administered. The 
median APACHE IV score of our population was 74 (IQR 
57–92) with a corresponding associated risk of in-hos-
pital mortality of 25%.38 At 90-day follow-up, 173 patients 
(25%, 95% CI 22% to 28%) had died, and 6 patients (1%, 
95% CI 0% to 2%) were lost to follow-up due to emigra-
tion or residence in another country.
Table 1 Specific research questions with add-on measurements53
Short title Research questions
Basic study Which combination of clinical variables obtainable through physical examination is associated 
with cardiac output measured by critical care ultrasonography (CCUS)53?
Which combination of clinical and haemodynamic variables is associated with 7-day, 30-day 
and 90-day mortality?
  1. NIRS What is the association of clinical and haemodynamic variables and tissue (muscle) oxygen 
saturation (StO2) measured by near-infrared spectroscopy (NIRS)?
Does the kneecap NIRS measurement have a better association with the clinical and 
haemodynamic variables than the NIRS measurement at the thenar muscle?
  2. Pulmonary ultrasound What is the association of a B-profile* measured with pulmonary ultrasonography and 
auscultation for pulmonary crackles with the diagnosis of pulmonary oedema by chest 
radiograph?
Is there a difference in cardiac output between the group with and without the presence of a 
B-profile?
  3. PEEP-challenge Does an increase in positive end-expiratory pressure (PEEP) correlate with a decrease in cardiac 
output?
  4. RV-function + mortality What is the association between right ventricular (RV)-function assessed with tricuspid annular 
plane systolic excursion and peak tissue Doppler systolic velocity in the tricuspid annulus (RV 
S’) with 90-day mortality?
What is the association between RV-function and clinical variables obtained from through 
physical examination?
  5. Abdominal flow Is there a correlation between cardiac output and peripheral blood flow measured with CCUS?
Can we calculate a proxy for abdominal organ blood flow by subtraction of peripheral flow to 
head and extremities from the cardiac output?
  6. FloTrac† What is the level of agreement between cardiac output measured by the FloTrac compared with 
cardiac output measured with CCUS?
Do the levels of agreement change when factors that might influence FloTrac measurements are 
present?
  7. Repeated measures What is the association of clinical variables with the cardiac output measured on two different 
time-points: one within the first 24 hours of admission and a second 24 hours thereafter
  8. RV-function + AKI Is RV volume overload measured by tricuspid insufficiency and RV diameter associated with 
acute kidney injury (AKI) ?
  9. Fluid responsiveness Do variations in end-tidal carbon dioxide (EtCO2), heart rate and blood pressure induced by the 
passive leg raising (PLR) test predict fluid responsiveness?
Does a PLR test without lowering the head of the bed have a similar accuracy compared with 
the standard PLR test?
Will a temporary increase of PEEP lead to a greater decrease in cardiac output in fluid 
responders compared with non-responders?
  10. ARDS What is the association between CCUS measurements and the presence or development of 
acute respiratory distress syndrome (ARDS) during the first 24 hours of ICU stay?
  11. Myocardial strain Is left ventricular and RV myocardial strain measured with tissue Doppler imaging a predictor of 
90-day mortality?
What is the association betweenmyocardial strain measured with tissue Doppler imaging and 
conventional CCUS measurements?
*B-profile: A B-profile is a strong indicator of pulmonary oedema and is present when three or more B lines are seen in at least three of the six 
BLUE points, or in two of the four lower BLUE points.54
†FloTrac: the FloTrac (Edwards Lifesciences, Irvine, California, USA) is a pulse contour technique that analyses the arterial pressure waveform 
to compute stroke volume and cardiac output. The technique consists a dedicated pressure sensor (FloTrac) and a monitor to compute stroke 
volume and cardiac output (Vigileo).55
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Critical care ultrasound
Cardiac output measurements by CCUS were performed 
in all the 704 included patients. After validation by the 
independent core laboratory 632 (90%, 95% CI 87% to 
92%) CCUS images were judged to be of sufficient quality 
for reliable cardiac output measurement. CCUS could 
not be performed in 68 patients due to various reasons 
obstructing the CCUS window, such as thoracic drains, 
postsurgical incisions, wounds or (subcutaneous) emphy-
sema (figure 2).
substudies
To date, we have initiated nine substudies that focus on 
more clinical or haemodynamic measurements (table 3). 
After evaluation of finished substudies (substudies 1–7), 
we considered ‘pulmonary ultrasound for the presence 
or absence of B-lines’ (substudy 2), ‘the right ventricle 
function’ (substudy 4), ‘validation of the FloTrac cardiac 
output measurement device’ (substudy 6) and ‘serial 
clinical and haemodynamic measurements’ (substudy 7) 
to be feasible. These substudies were successively imple-
mented in the basic study line and data collection is still 
ongoing. Substudies 1, 3 and 5 were discontinued as 
results appeared inaccurate or were too time-consuming. 
Currently, two substudies are running (8 and 9), and two 
new substudies are planned (10 and 11) (figure 1).
Future perspectives
In the near future, we aim to expand our SICS studies 
to patients in the emergency room, independent of their 
destination ward in the hospital. We expect that both the 
diagnostic and prognostic value of available clinical and 
haemodynamic variables will change when patients are 
included in earlier phase of acute illness. Other future 
possibilities may include even more advanced CCUS 
imaging, other specific haemodynamic research ques-
tions and expansion to other national and/or interna-
tional centres. Ultimately a randomised clinical trial for 
evaluation of haemodynamic interventions may be super-
imposed on this registry with the ultimate goal to improve 
patient-centred outcomes.39
strengths And lImItAtIons
We have described the study protocol including the 
research questions and design as well as the character-
istics of the patients included in the cohort so far. The 
strengths of the study include the prospective design 
allowing systematic data collection following a predefined 
protocol. All variables are measured according to strict 
definitions in a broad ICU population that represents the 
daily critical care in a university hospital. We already learnt 
that values of clinical and haemodynamic variables show 
large individual differences in the critically ill patients of 
the SICS-I cohort. Currently in critical care all patients 
are assessed by the same combination of clinical and 
haemodynamic variables. It is very likely that these vari-
ables will have different diagnostic and prognostic value 
depending on patient subgroups. A more personalised 
approach for clinical and haemodynamic assessment in 
Figure 2 Flow diagram of the Simple Intensive Care Studies-I (SICS-I) cohort. CCUS, critical care ultrasonography
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this heterogeneous population seems to be appropriate. 
We therefore aim to include a sufficient number of criti-
cally ill patients to establish the additional diagnostic and 
prognostic value of specific clinical and haemodynamic 
variables in predefined subgroups, for example, patients 
with sepsis, shock or acute respiratory distress syndrome.
Another strength is the flexible design that allows 
temporary or definite incorporation of specific haemo-
dynamic research questions. This design facilitates a 
combined evaluation of clinical and haemodynamic 
variables used in daily practice and offers the possibility 
of evaluating whether new and/or advanced measure-
ments can improve diagnostic and prognostic accuracy. 
Furthermore, evaluations of substudies adapt the set of 
clinical and haemodynamic variables to be measured in 
the basic study line. Evaluations of inclusions or exclu-
sions of variables are based on the additional diagnostic 
and prognostic value as well as the efforts and possible 
interference with patient care needed for recording.
A lesson learnt from this cohort study is that novices, 
that is, senior medical and PhD students, can be effec-
tively trained to obtain advanced haemodynamic vari-
ables derived from CCUS. While previous studies showed 
that non-cardiological professionals could obtain reliable 
CCUS images and measurements after an education 
programme,40–42 we demonstrated that this possibility 
Table 2 Clinical, haemodynamic and biochemical variables of the basic study
Variable Total population (n=704)
Clinical variables
  Age, years* 61±15
  Male gender, n (%) 457 (65%, 95% CI 61% to 68%)
  Body mass index, kg/m²* 26.83±5.87
  Time to inclusion, hours† 14.9 (8.2, 19.8)
  Mechanical ventilation, n (%) 415 (59%, 95% CI 58% to 62%)
  Positive end-expiratory pressure, cmH2O
† 7 (5, 8)
  Heart rate, beats per min* 89±21
  Atrial fibrillation, n (%) 47 (7%, 95% CI 5% to 9%)
  Systolic blood pressure, mm Hg† 114 (100, 132)
  Diastolic blood pressure, mm Hg† 58 (52, 65)
  Mean arterial pressure, mm Hg† 75 (68, 86)
  Central venous pressure, mm Hg† 9 (5, 13)
  Urine output over 1 hour, mL/kg/h† 0.52 (0.26, 1.07)
  Urine output over 6 hours, mL/kg/h† 0.56 (0.32, 1.06)
  Central temperature, °C* 37.0±0.9
  Peripheral temperature, °C* 28.1±4.0
  Central-to-peripheral delta temperature, °C* 9.0±3.9
  Cold extremities, subjective, n (%) 276 (39%, 95% CI 35% to 43%)
  Capillary refill time sternum, s† 3.0 (2.0, 3.0)
  Capillary refill time finger, s† 2.5 (2.0, 4.0)
  Capillary refill time knee, s† 3.0 (2.0, 5.0)
  Mottling score
   Mild (grade 1) 71 (11%, 95% CI 9% to 14%)
   Moderate (grades 2–3) 197 (30%, 95% CI 27% to 34%)
   Severe (grades 4–5) 31 (5%, 95% CI 3% to 7%)
Haemodynamic variables
  Cardiac output, L/min* 5.20±1.96
  Cardiac index, L/min/m2* 2.63±0.99
Biochemical values
  Haemoglobin, mmol/L* 6.7±1.5
  Lactate, mmol/L† 1.5 (0.9, 2.3)
*Mean±SD.
†Median (IQR).
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seems to apply to novices as well. Recently, CCUS is increas-
ingly applied in different areas of medicine including the 
prehospital phase, the emergency department and the 
ICU setting.42–46 CCUS is highly operator dependent and 
time consuming. Due to validation of all our measure-
ments by an echographic core laboratory, we ensured the 
quality of our echographic images and accuracy of the 
related measurements. Despite training and independent 
validation of our measurements, the quality and accuracy 
of our images may still be inferior compared with those 
obtained by skilled echolaboratory technicians, cardiolo-
gists, intensivists or cardiologist-intensivists. However, our 
researchers scheduled themselves 7 days a week and can 
easily expand to other potential study locations. A limita-
tion inherent to the technique is that CCUS cannot be 
performed in patients with pathology interfering with a 
proper ultrasound window view, such as drains, wounds 
and subcutaneous emphysema. This limitation will, 
however, apply to both inexperienced and experienced 
investigators.
One limitation for statistical interference of the current 
study design is that we will encounter multiplicity issues 
due to multiple testing of the data across substudies. 
Repeated testing may result in increased type I errors. 
Additionally, all substudies need separate detailed 
sample size considerations. As a rule of thumb, at least 
10 events are necessary for each variable included in a 
final model.47 48 To account for this potential multiplicity 
issue combined with multiple sample size considerations, 
we emphasise the hypothesis-generating aspect of results 
and advocate that findings should be validated in an inde-
pendent cohort.
Another major limitation of our SICS-I basic study is 
that all measurements are limited to a single time point. 
To expect, for example, that one single cardiac output 
measurement may predict mortality is obviously unre-
alistic as cardiac output may vary widely over time.49 50 
One of our substudies specifically aims to determine the 
diagnostic accuracy of continuously monitoring cardiac 
output in patients with shock. Other CCUS measure-
ments with less variation over time might eventually 
appear to be better predictors, and we are currently 
exploring which set of CCUS measurements may accom-
modate clinical needs. However, in daily practice, snap-
shot measurements guide treatment decisions as triggers 
for interventions. Ideally, decisions for interventions 
will be informed by (trends of) repeated or even contin-
uous measurements of both cardiac output and other 
Table 3 Clinical or haemodynamic variables measured in substudies
No Variable (units) Abbreviation Method of measuring N
1 Peripheral tissue oxygen saturation (%) StO2 Near-infrared spectroscopy 29
2+10 Vertical hyperechoic artefacts (‘rocket beams’) (n) B-lines CCUS 556
3+9 Change in cardiac output with PEEP increase (L/
min)
ΔCO-PEEP CCUS 11
4 Tricuspid annular peak systolic excursion (mm) TAPSE CCUS 391
4 Right ventricle S’ of the tricuspid annulus (cm/s) RV S’ CCUS 373
5 Common carotid artery flow (L/min) CCA flow CCUS 59
5 Subclavian artery flow (L/min) SCA flow CCUS 59
5 Common femoral artery flow (L/min) CFA flow CCUS 59
5 Abdominal flow (L/min) – Calculation: Cardiac output − (CCA flow 
+ SCA flow + CFA flow)
59
6* Cardiac output calculated with FloTrac (L/min) APCO Arterial pressure waveform analysis 14
7* Repeated measurements Δ-measures of 
basic study
46
8 Tricuspid insufficiency (cm/s) TI CCUS 39
8 Right ventricle end systolic diameter (mm) RVESd CCUS 78
9 Delta heart rate (bpm) ΔHR Bedside monitor 3
9 Delta-systolic, diastolic and mean arterial 
pressures (mm Hg)
ΔSBP, ΔDBP, 
ΔMAP
Bedside monitor 3
9 Delta expiratory end-tidal carbon dioxide 
(cmH2O)
ΔEtCO2 Mechanical ventilator 3
10 Presence or absence of ARDS – Chest radiography –
11 Myocardial strain (%) Ɛ CCUS –
11 Myocardial strain rate (1/s) Ɛ / SR CCUS –
*Sub-studies 6 and 7 include only patients in a state of circulatory shock.
ARDS, acute respiratory distress syndrome; CCUS, critical care ultrasound; N,number; PEEP, positive end-expiratory pressure.
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haemodynamic variables. Continuous measurement is 
limited to the variables heart rate, blood pressures and 
non-invasively measured cardiac output. The use of either 
invasive or non-invasive continuous monitoring of cardiac 
output has no documented benefit on mortality,51 which 
might result from either lack of prognostic additive value, 
insufficient diagnostic accuracy, the treatment algorithm 
used or absence of any beneficial effects of the selected 
treatment interventions.52 The entire process of setting 
the correct diagnosis, implementing an appropriate 
intervention, monitoring treatment effect and eventu-
ally improving patient prognosis in a haemodynamically 
unstable patient is an extremely complex chain of events. 
Evidence-based evaluation of such a process with complex 
time-dependent repeated interactions between diag-
nosis and treatment requires an approach that includes 
all three types of research: diagnostic, prognostic and a 
combination of intervention with prognostic research. 
For the latter, our study could serve as an infrastructure 
to conduct randomised clinical trials.
CollAborAtIon
We have described the study protocol and the characteris-
tics of the patients. The aim of the SICS-I study is to serve 
as a pilot for a large, multicentre, preferably multinational 
registry aimed at evaluating simple clinical and haemody-
namic measures to guide treatment decisions focused on 
haemodynamics. Our experience with the SICS-I will fuel 
future projects and the selection of clinical and haemody-
namic variables in large-scale collaborations. This experi-
ence has already led to an ongoing collaboration with the 
Copenhagen Trial Unit, the Centre for Research in Inten-
sive Care and The Division of Intensive Care Medicine of 
the Helsinki University Hospital, and we are open for any 
further suggestions or proposals for collaboration.
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